Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 12.95 INR
Change Today +0.55 / 4.44%
Volume 375.0
BRPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

brawn biotech ltd (BRPH) Snapshot

Open
13.00
Previous Close
12.40
Day High
13.00
Day Low
11.78
52 Week High
04/28/15 - 17.70
52 Week Low
09/9/14 - 4.41
Market Cap
38.9M
Average Volume 10 Days
251.5
EPS TTM
0.95
Shares Outstanding
3.0M
EX-Date
--
P/E TM
13.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for BRAWN BIOTECH LTD (BRPH)

Related News

No related news articles were found.

brawn biotech ltd (BRPH) Related Businessweek News

No Related Businessweek News Found

brawn biotech ltd (BRPH) Details

Brawn Biotech Limited operates as a healthcare group in India and internationally. The company involves in manufacturing, contract manufacturing, and supplying pharmaceutical and healthcare products. It provides various pharmaceutical products, including antibacterial, cardiovascular, anti diabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. Brawn Biotech Limited was founded in 1985 and is based in New Delhi, India.

Founded in 1985

brawn biotech ltd (BRPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

brawn biotech ltd (BRPH) Key Developments

Brawn Biotech Limited Announces Unaudited Standalone Earnings Results for Third Quarter and Nine Months Ended December 31, 2014

Brawn Biotech Limited announced unaudited standalone earnings results for third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 114.767 million, profit from operations before other income, finance costs and exception items of INR 1.501 million, profit from ordinary activities before tax of INR 1.480 million, net profit of INR 0.840 million or INR 0.28 per basic and diluted share after extraordinary items compared to the net sales/income from operations (net of excise duty) of INR 88.424 million, profit from operations before other income, finance costs and exception items of INR 1.482 million, loss from ordinary activities before tax of INR 2.756 million, net loss of INR 2.228 million or INR 0.74 per basic and diluted share after extraordinary items for the same quarter a year ago. For the nine months, the company reported net sales/income from operations (net of excise duty) of INR 302.157 million, profit from operations before other income, finance costs and exception items of INR 3.020 million, profit from ordinary activities before tax of INR 3.096 million, net profit of INR 2.149 million or INR 0.72 per basic and diluted share after extraordinary items compared to the net sales/income from operations (net of excise duty) of INR 272.534 million, profit from operations before other income, finance costs and exception items of INR 9.231 million, profit from ordinary activities before tax of INR 4.833 million, net profit of INR 3.339 million or INR 0.11 per basic and diluted share after extraordinary items for the same period a year ago.

Brawn Biotech Limited, Board Meeting, Feb 13, 2015

Brawn Biotech Limited, Board Meeting, Feb 13, 2015. Agenda: To consider unaudited standalone earnings results for third quarter and nine months ended December 31, 2014.

Brawn Biotech Limited Announces Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended Sept. 30, 2014

Brawn Biotech Limited announced unaudited standalone earnings results for second quarter and six months ended Sept. 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 112.675 million, profit from operations before other income, finance costs and exception items of INR 0.528 million, profit from ordinary activities before tax of INR 0.625 million, net profit of INR 0.625 million or INR 0.21 per basic and diluted share after extraordinary items compared to the net sales/income from operations (net of excise duty) of INR 105.083 million, loss from operations before other income, finance costs and exception items of INR 0.577 million, loss from ordinary activities before tax of INR 0.718 million, net loss of INR 0.718 million or INR 0.24 per basic and diluted share after extraordinary items for the same quarter a year ago. For the year to date, the company reported net sales/income from operations (net of excise duty) of INR 187.39 million, profit from operations before other income, finance costs and exception items of INR 1.52 million, profit from ordinary activities before tax of INR 1.617 million, net profit of INR 1.31 million or INR 0.44 per basic and diluted share after extraordinary items compared to the net sales/income from operations (net of excise duty) of INR 184.11 million, profit from operations before other income, finance costs and exception items of INR 7.749 million, profit from ordinary activities before tax of INR 7.589 million, net profit of INR 5.567 million or INR 1.86 per basic and diluted share after extraordinary items for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRPH:IN 12.95 INR +0.55

BRPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BRPH.
View Industry Companies
 

Industry Analysis

BRPH

Industry Average

Valuation BRPH Industry Range
Price/Earnings 100.0x
Price/Sales 0.1x
Price/Book 0.8x
Price/Cash Flow 121.9x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BRAWN BIOTECH LTD, please visit www.brawnpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.